Wyss Institute launches Opsonix to commercialize its pathogen-extracting sepsis therapy

(Wyss Institute for Biologically Inspired Engineering at Harvard) The Wyss Institute for Biologically Inspired Engineering at Harvard University has unveiled the launch of its startup company Opsonix Inc. The announcement follows a worldwide licensing agreement between Harvard's Office of Technology Development and Opsonix Inc. enabling the company to ready the Wyss-designed sepsis therapy for clinical use.